We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Tristel Plc | LSE:TSTL | London | Ordinary Share | GB00B07RVT99 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
15.00 | 3.23% | 480.00 | 460.00 | 480.00 | 470.00 | 465.00 | 465.00 | 33,518 | 16:35:01 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Med, Dental, Hosp Eq-whsl | 36.01M | 4.46M | 0.0941 | 49.95 | 222.78M |
Date | Subject | Author | Discuss |
---|---|---|---|
12/7/2021 08:31 | It's all fine by me - I first bought these at 30p so I have a very nice return and I fail to see why the directors should not. If the performance dips then it is another story but so far they have done a great job and are one of the few companies that seem to actually value their shareholders having been to several of their open days | q2u | |
12/7/2021 07:30 | The unusual thing for m is the market always seems to act positively to a further equity issue | best1467 | |
11/7/2021 00:33 | Here is TSTL in 2018, - when the share price was in the £2.50 - £3.00 range I wonder what would make a good indicator - Issue of Equity vs. Turnover, Market Cap. or perhaps N° of employees? | piedro | |
11/7/2021 00:24 | Here is for MGNS, Morgan Sindall a construction company - still in the 46 millions after more than one year - share price from £10 to £20 in one year - perhaps no comparison Will Tristel slow down the rhythm when the share price is £10 | piedro | |
10/7/2021 11:02 | Nope. apad | apad | |
10/7/2021 10:52 | Issue of Equity ... Does anyone know of another company with such prolific issuing? | piedro | |
07/7/2021 11:09 | Old news new look ... 6 July, 2021 By Tony Quested Tristel disinfectant product wins key US approval A potentially lucrative product drive in the United States for Tristel plc in Newmarket has been underpinned by receipt of a key approval from the United States Environmental Protection Agency (EPA). It originally granted Tristel approval for Jet – its foam-based disinfectant for surfaces – in April 2018. | piedro | |
25/6/2021 07:01 | Latest product ... Daisy Grip Daisygrip is the first hygienically reusable venous tourniquet and has a unique intuitive locking system. The simpler application and disinfection method ensure lasting safety and permanently reduce costs. With daisygrip, every routine blood sample is taken time-efficiently and under hygienic conditions, without changing current treatment procedures. | piedro | |
25/6/2021 06:57 | Renewed web site split between and, - much cleaner IMO - but what do you make of the bod photos? | piedro | |
24/6/2021 13:56 | Approval for US, Canada and S Korea and an outsourcing manufacturer.Just need to start generating sales now. | paulisi | |
19/6/2021 11:00 | FYI, Increasing Endoscopy Capacity For Royal Derby JUN 15, 2021 | piedro | |
28/5/2021 18:45 | 'Not dissimilar', that should have read | leopoldalcox | |
28/5/2021 18:44 | Well put James188. I've not sold any. I'm here for the long term growth. It's not similar to the situation at BXP. That is moving will expectations of the covid vaccine rollout, in which BXP is involved. It has sold off quite a lot recently with news that the roll out is being delayed by production issues. But the growth in the underlying business is the reason to hold that one as well | leopoldalcox | |
28/5/2021 18:36 | All they said was short term weakness with recovery - and then ensued a hiss and fit from all sundry - I don't predict but happy to hold unless it completely loses trend which it hasn't | davr0s | |
28/5/2021 18:33 | Maybe people have twigged that there is a huge backlog of routine/elective procedures that need to be dealt with. The so called tsunami. That has to benefit TSTL. The irony is that COVID-19 was initially viewed as a major opportunity (and it is), but the core business is what really counts. I really like the fact that TSTL is hedged either way at the moment. Surface disinfectants is an important play, but instrument disinfection is a proven long term earner. The PE may be high, but I am still adding. | james188 | |
28/5/2021 18:15 | Slowly grinding back up despite all that recent negativity | davr0s | |
03/5/2021 13:30 | Is anyone on this board looking at HEIQ which has similarities to TSTL? I m not pumping the share. I held TSTL and made a good profit some years ago (from100p to 350p)Wish I hadn't sold out. Reply on HEIQ board | petewy | |
28/4/2021 14:33 | I've been rereading the 'Tristel Open Day – Shareholder Q&A' - 22/07/2020 - it gives a good down-to-earth summary of where the company is at. - as well as the later 'Tristel Interim Results – Shareholder Q&A' - 02/03/2021 | piedro | |
28/4/2021 13:52 | I don't think you will learn much about future price direction from bulletin boards.... | davr0s | |
28/4/2021 11:19 | Reading the boards letter I am not convinced that recovery will be quick. I sold yesterday and will watch the price and the final results with interest as I want to get back in at a much lower price. | anley | |
27/4/2021 10:24 | SKH My opinion of you as changed with your posts on this and BYTL thread you clearly have an agenda and you post to suit your cause you are as posters suggested a LLSB | best1467 | |
27/4/2021 10:08 | From the above study ... - seems they overlooked proper cleaning of the "Monitor" and "Inside door handle" in the Control Group. | piedro | |
27/4/2021 09:28 | FWIW, an interesting study ... American Journal of Infection Control Effectiveness of dry hydrogen peroxide on reducing environmental microbial bioburden risk in a pediatric oncology intensive care unit Marilyn Ramirez RN, Laura Matheu RN, Miguel Gomez RN, Alicia Chang MD, Jose Ferrolino MD, MPH, Ricardo Mack MD, Federico Antillon-Klussmann MD, Mario Melgar MD Background: Routine manual cleaning and disinfection of the health care environment is often suboptimal. Residual contamination poses an infection risk, particularly for immunocompromised patients. This study evaluates the efficacy of dry hydrogen peroxide (DHP) on microbial surface contamination in a pediatric oncology intensive care unit. Conclusions: Study demonstrates that DHP was effective in reducing microbial surface contamination and improves quality of environmental cleaning. © 2020 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. | piedro | |
26/4/2021 21:45 | The CDC recently changed its stance on how Covid-19 is spread Previously it had said fomites on surfaces was the cause Now it says it is airborne droplets Soon the scientific community will get the CDC to say what the cause truly is : Aerosol transmission up to 11 metres distance indoors and Covid-19 aerosols stay suspended in the air indoors for hours dependent on humidity levels. -------------------- Top Canadian WHO adviser under fire after downplaying airborne threat of COVID-19 The WHO are now looking even more behind the curve with their continued surface spread mantra They too will soon imo have to use modern terminology like 'aerosol' in their next update Chartwise 480p looks next imo dyor | buywell3 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions